Issued Patents All Time
Showing 1–25 of 226 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12428653 | Gene therapy for ceroid lipofuscinoses | Nathan Katz, Christian Hinderer, Juliette Hordeaux | 2025-09-30 |
| 12416016 | Adeno-associated virus (AAV) vectors, AAV vectors having reduced capsid deamidation and uses therefor | April Tepe, Kevin Turner, Joshua Joyner Sims, Qiang Wang | 2025-09-16 |
| 12416017 | Recombinant adeno-associated virus for treatment of GRN-associated adult-onset neurodegeneration | Christian Hinderer, Nimrod Miller | 2025-09-16 |
| 12385065 | Gene therapy for treating citrullenemia | Jenny Agnes Sidrane, Lili Wang | 2025-08-12 |
| 12338451 | Compositions useful in treatment of metachromatic leukodystrophy | Juliette Hordeaux | 2025-06-24 |
| 12221615 | GLP-1 and use thereof in compositions for treating metabolic diseases | Christian Hinderer, Matthew J. WILSON | 2025-02-11 |
| 12023386 | Composition for treatment of Crigler-Najjar syndrome | Anna P. Tretiakova, Jenny Agnes Sidrane | 2024-07-02 |
| 11890329 | AAV9-mediated gene therapy for treating mucopolysaccharidosis type I | Christian Hinderer | 2024-02-06 |
| 11865187 | Methods and compositions for treating metastatic breast cancer and other cancers in the brain | William Thomas Rothwell, Christian Hinderer | 2024-01-09 |
| 11862329 | Pathogen detection and display system | Charles R. Sperry, Lawrence J. Pillote, Vincent A. Piucci, Dennis F. McNamara, Jr., Lisa Ruth Stowe +3 more | 2024-01-02 |
| 11827906 | Adeno-associated virus (AAV) clade f vector and uses therefor | Qiang Wang, April Tepe, Kevin Turner | 2023-11-28 |
| 11819539 | Gene therapy for treating Mucopolysaccharidosis type II | Christian Hinderer | 2023-11-21 |
| 11807866 | Simian adenoviruses SAdV-43, -45, -46, -47, -48, -49, and -50, and uses thereof | Soumitra Roy, Luc H. Vandenberghe | 2023-11-07 |
| 11779656 | Gene therapy for treating hemophilia A | Lili Wang, Jenny Agnes Sidrane | 2023-10-10 |
| 11766448 | Compositions and methods for altering tissue specificity and improving AAV9-mediated gene transfer | Christie L. Bell, Luc H. Vandenberghe | 2023-09-26 |
| 11732246 | Compositions useful in treatment of ornithine transcarbamylase (OTC) deficiency | Lili Wang | 2023-08-22 |
| 11723989 | Gene therapy for mucopolysaccharidosis IIIB | Christian Hinderer, Juliette Hordeaux | 2023-08-15 |
| 11680274 | Method of increasing the function of an AAV vector | Luk H. Vandenberghe, Guangping Gao | 2023-06-20 |
| 11591614 | Gene therapy for ceroid lipofuscinoses | Nathan Katz, Christian Hinderer, Juliette Hordeaux | 2023-02-28 |
| 11578341 | Compositions useful in treatment of spinal muscular atrophy | Christian Hinderer, Nathan Katz, Qiang Wang | 2023-02-14 |
| 11555206 | Gene therapy for mucopolysaccharidosis IIIA | Nathan Katz, Juliette Hordeaux | 2023-01-17 |
| 11555059 | LDLR variants and their use in compositions for reducing cholesterol levels | Daniel J. Rader, Suryanrayan Somanathan | 2023-01-17 |
| 11554147 | Gene therapy for treating familial hypercholesterolemia | Daniel J. Rader | 2023-01-17 |
| 11535665 | AAV-mediated expression of anti-influenza antibodies and methods of use thereof | Maria P. Limberis, Anna P. Tretiakova | 2022-12-27 |
| 11535866 | Gene therapy for treating citrullenemia | Jenny Agnes Sidrane, Lili Wang | 2022-12-27 |